Health care pharmaceutical companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Edgewise Therapeutics has the lowest figure of the 33 health care pharmaceutical companies ranked by P/E ratio, at 4.9, followed by Alnylam Pharmaceuticals (7.5) and Novo Nordisk (9.8). Figures as of 20 Nov 2026, 06:58 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 33
- Lowest
- Edgewise Therapeutics4.9
- Median
- 39.3
- Combined market value
- SEK 50.46T
- Countries
- 10
- Not ranked
- 28no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | P/E ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Edgewise TherapeuticsEWTX · Health Care | 4.9 | SEK 45.8B | SEK 418.65 | 0.48% down | 86% up | ||
| 2 | Alnylam PharmaceuticalsALNY · Health Care | 7.5 | SEK 201.3B | SEK 1,503.17 | 1.06% down | 66% down | ||
| 3 | Novo NordiskNVO · Health Care | 9.8 | SEK 1.74T | SEK 395.27 | 1.42% down | 17% down | ||
| 4 | GrifolsGRFS · Health Care | 9.9 | SEK 56.8B | SEK 83.39 | 3.19% down | 0% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | 12.9 | SEK 1.21T | SEK 593.25 | 2.05% down | 30% up | ||
| 6 | ZoetisZTS · Health Care | 13.7 | SEK 333.8B | SEK 821.55 | 5.59% down | 26% down | ||
| 7 | GSKGSK · Health Care | 16.4 | SEK 974.7B | SEK 486.28 | 1.56% down | 5% up | ||
| 8 | Ascendis PharmaASND · Health Care | 16.8 | SEK 170.7B | SEK 2,602.84 | 5.32% down | 29% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | 20.4 | SEK 971.3B | SEK 9,389.37 | 2.35% down | 28% up | ||
| 10 | United TherapeuticsUTHR · Health Care | 21.1 | SEK 242.1B | SEK 5,685.44 | 3.16% down | 22% up | ||
| 11 | SanofiSNY · Health Care | 22.9 | SEK 1.12T | SEK 468.38 | 2.25% down | 4% down | ||
| 12 | AstraZenecaAZN · Health Care | 24.8 | SEK 2.77T | SEK 1,783.73 | 1.87% down | 1% up | ||
| 13 | Protagonist TherapeuticsPTGX · Health Care | 26.9 | SEK 82.3B | SEK 1,261.15 | 2.47% down | 51% up | ||
| 14 | NovartisNVS · Health Care | 29.6 | SEK 2.9T | SEK 1,537.74 | 2.57% down | 25% up | ||
| 15 | Vertex PharmaceuticalsVRTX · Health Care | 33.5 | SEK 1.34T | SEK 5,294.55 | 2.94% down | 27% up | ||
| 16 | Abbott LaboratoriesABT · Health Care | 38.8 | SEK 1.83T | SEK 1,056.25 | 0.58% down | 16% down | ||
| 17 | PfizerPFE · Health Care | 39.3 | SEK 1.6T | SEK 280.05 | 1.85% down | 15% up | ||
| 18 | Johnson & JohnsonJNJ · Health Care | 40.5 | SEK 6.54T | SEK 2,716.53 | 2.04% down | 34% up | ||
| 19 | Dr. Reddy's LaboratoriesRDY · Health Care | 41.2 | SEK 125.7B | SEK 150.81 | 1.00% down | 8% up | ||
| 20 | Eli LillyLLY · Health Care | 43.9 | SEK 12.24T | SEK 13,739.43 | 2.29% down | 33% up | ||
| 21 | GenmabGMAB · Health Care | 43.9 | SEK 322B | SEK 522.17 | 0.75% up | 70% up | ||
| 22 | Royalty PharmaRPRX · Health Care | 44.3 | SEK 396B | SEK 688.64 | 1.38% down | 79% up | ||
| 23 | AbbVieABBV · Health Care | 48.7 | SEK 5.1T | SEK 2,883.30 | 0.86% down | 25% up | ||
| 24 | Corcept TherapeuticsCORT · Health Care | 48.9 | SEK 72.3B | SEK 660.78 | 4.15% down | 10% down | ||
| 25 | BeOne MedicinesONC · Health Care | 51.2 | SEK 464.3B | SEK 4,064.52 | 0.97% down | 16% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | 53.5 | SEK 75.8B | SEK 217.51 | 2.24% down | 90% up | ||
| 27 | Jazz PharmaceuticalsJAZZ · Health Care | 70.0 | SEK 154.3B | SEK 2,404.44 | 4.57% down | 41% up | ||
| 28 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 70.9 | SEK 74.7B | SEK 951.15 | 1.59% down | 129% up | ||
| 29 | Teva Pharmaceutical IndustriesTEVA · Health Care | 89.6 | SEK 457.3B | SEK 391.91 | 8.74% down | 74% up | ||
| 30 | TG TherapeuticsTGTX · Health Care | 96.8 | SEK 99.7B | SEK 659.76 | 1.88% down | 117% up | ||
| 31 | Ligand PharmaceuticalsLGND · Health Care | 115 | SEK 58.4B | SEK 2,917.87 | 3.94% down | 50% up | ||
| 32 | Merck & CoMRK · Health Care | 134 | SEK 3.33T | SEK 1,350.53 | 3.61% down | 45% up | ||
| 33 | Takeda PharmaceuticalTAK · Health Care | 306 | SEK 695.6B | SEK 217.72 | 0.66% up | 51% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1689 SEK). 28 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies have the lowest P/E ratio?
Edgewise Therapeutics (4.9), Alnylam Pharmaceuticals (7.5) and Novo Nordisk (9.8) have the lowest P/E ratio of the 33 health care pharmaceutical companies ranked here as of 20 Nov 2026, 06:58 UTC.
How many health care pharmaceutical companies are in this ranking?
33 are ranked by P/E ratio. 28 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 33 health care pharmaceutical companies ranked by P/E ratio have a combined market value of SEK 50.46T as of 20 Nov 2026, 06:58 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by P/E ratio”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.